← Open Payments lookup

MILLICENT MUTISYA: Open Payments

NPI 1285308528 · FAIRFAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$334 in 14 payments from 13 companies in 2025. Trend: 2023 $320 · 2024 $425 · 2025 $334

Food & beverage: $334
CompanyPaymentsAmount
Lilly USA, LLC2$46
Syndax Pharmaceuticals, Inc.1$34
Coherus Oncology, Inc.1$27
Takeda Pharmaceuticals U.S.A., Inc.1$26
AstraZeneca Pharmaceuticals LP1$26
Exelixis Inc.1$26
Incyte Corporation1$25
ARRAY BIOPHARMA INC1$23
GENZYME CORPORATION1$22
Novartis Pharmaceuticals Corporation1$22

Products named: Udenyca, ICLUSIG, LYNPARZA, CABOMETYX, Jakafi, JAYPIRCA, LORBRENA, SARCLISA.

Industry payments across VA — which companies pay providers there.